{
     "PMID": "21789566",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20120316",
     "LR": "20171030",
     "IS": "1573-7365 (Electronic) 0885-7490 (Linking)",
     "VI": "26",
     "IP": "3",
     "DP": "2011 Sep",
     "TI": "Effects of oxcarbazepine on monoamines content in hippocampus and head and body shakes and sleep patterns in kainic acid-treated rats.",
     "PG": "213-20",
     "LID": "10.1007/s11011-011-9254-x [doi]",
     "AB": "The aim of this work was to analyze the effect of oxcarbazepine (OXC) on sleep patterns, \"head and body shakes\" and monoamine neurotransmitters level in a model of kainic-induced seizures. Adult Wistar rats were administered kainic acid (KA), OXC or OXC + KA. A polysomnographic study showed that KA induced animals to stay awake for the whole initial 10 h. OXC administration 30 min prior to KA diminished the effect of KA on the sleep parameters. As a measure of the effects of the drug treatments on behavior, head and body shakes were visually recorded for 4 h after administration of KA, OXC + KA or saline. The presence of OXC diminished the shakes frequency. 4 h after drug application, the hippocampus was dissected out, and the content of monoamines was analyzed. The presence of OXC still more increased serotonin, 5-hidroxyindole acetic acid, dopamine, and homovanilic acid, induced by KA.",
     "FAU": [
          "Alfaro-Rodriguez, Alfonso",
          "Gonzalez-Pina, Rigoberto",
          "Bueno-Nava, Antonio",
          "Arch-Tirado, Emilio",
          "Avila-Luna, Alberto",
          "Uribe-Escamilla, Rebeca",
          "Vargas-Sanchez, Javier"
     ],
     "AU": [
          "Alfaro-Rodriguez A",
          "Gonzalez-Pina R",
          "Bueno-Nava A",
          "Arch-Tirado E",
          "Avila-Luna A",
          "Uribe-Escamilla R",
          "Vargas-Sanchez J"
     ],
     "AD": "Departamento de Neurofisiologia, Laboratorio de Neuroquimica, Instituto Nacional de Rehabilitacion, SSA, Calz. Mexico-Xochimilco 289 Col. Arenal de Guadalupe, Delegacion Tlalpan, C.P. 14389 Mexico City, Mexico. alfa1360@yahoo.com.mx",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20110726",
     "PL": "United States",
     "TA": "Metab Brain Dis",
     "JT": "Metabolic brain disease",
     "JID": "8610370",
     "RN": [
          "0 (Anticonvulsants)",
          "333DO1RDJY (Serotonin)",
          "33CM23913M (Carbamazepine)",
          "54-16-0 (Hydroxyindoleacetic Acid)",
          "SIV03811UC (Kainic Acid)",
          "VTD58H1Z2X (Dopamine)",
          "VZI5B1W380 (oxcarbazepine)",
          "X77S6GMS36 (Homovanillic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Anticonvulsants/administration & dosage/therapeutic use",
          "Carbamazepine/administration & dosage/*analogs & derivatives/therapeutic use",
          "Disease Models, Animal",
          "Dopamine/*metabolism",
          "Hippocampus/*drug effects",
          "Homovanillic Acid/metabolism",
          "Hydroxyindoleacetic Acid/metabolism",
          "Kainic Acid/adverse effects",
          "Male",
          "Rats",
          "Rats, Wistar",
          "Seizures/chemically induced/*drug therapy",
          "Serotonin/*metabolism",
          "Sleep Stages/*drug effects"
     ],
     "EDAT": "2011/07/27 06:00",
     "MHDA": "2012/03/17 06:00",
     "CRDT": [
          "2011/07/27 06:00"
     ],
     "PHST": [
          "2011/02/14 00:00 [received]",
          "2011/07/13 00:00 [accepted]",
          "2011/07/27 06:00 [entrez]",
          "2011/07/27 06:00 [pubmed]",
          "2012/03/17 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s11011-011-9254-x [doi]"
     ],
     "PST": "ppublish",
     "SO": "Metab Brain Dis. 2011 Sep;26(3):213-20. doi: 10.1007/s11011-011-9254-x. Epub 2011 Jul 26.",
     "term": "hippocampus"
}